SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-19-022404
Filing Date
2019-11-07
Accepted
2019-11-07 17:24:46
Documents
2
Group Members
ORBIMED ISRAEL GP LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d1119orbimed_biomxinc.htm SC 13D 69988
2 JOINT FILING AGREEMENT BETWEEN ORBIMED ISRAEL GP LTD. AND ORBIMED ISRAEL BIOFUND sc13d1119ex99-1_biomxinc.htm EX-99.1 5246
  Complete submission text file 0001213900-19-022404.txt   76854
Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 1022-4629
Business Address 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR HERZLIYA L3 46766 212-739-6400
OrbiMed Israel BioFund GP Limited Partnership (Filed by) CIK: 0001569821 (see all company filings)

IRS No.: 980697985 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004 646-465-9000
BiomX Inc. (Subject) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90744 | Film No.: 191201399
SIC: 6770 Blank Checks